E-LIB Suche - Ergebnisse für: Cortesi, P.

1

EE362 A Budget Impact Analysis of Pertuzumab, Trastuzumab, ..:

Antonazzo, I.C. ; Bengala, C. ; Biganzoli, L....
Value in Health. 26 (2023) 12 - p. S121 , 2023

Link: https://doi.org/10.1016/..

2

PCR191 Assessing Quality of Care in Haemophilia Using a Val..:

Fornari, C. ; Cortesi, P.A. ; Conti, S....
Value in Health. 26 (2023) 12 - p. S485-S486 , 2023

Link: https://doi.org/10.1016/..

3

51P Phase IB (Ph1b), MESOVAX clinical trial of pembrolizuma..:

Ridolfi, L. ; Delmonte, A. ; De Rosa, F....
Immuno-Oncology and Technology. 20 (2023) - p. 100524 , 2023

Link: https://doi.org/10.1016/..

4

HTA179 Environmental Impact and Health Technology Assessmen..:

Antonazzo, I.C. ; Cortesi, P. ; Ferrara, P....
Value in Health. 26 (2023) 12 - p. S353 , 2023

Link: https://doi.org/10.1016/..

5

Dynamics and costs of patients with appropriate, Уtoo early..:

Tamburrino, Domenico ; Cortesi, P. ; Facchetti, R....
Pancreatology. 22 (2022) - p. e31 , 2022

Link: https://doi.org/10.1016/..

6

48P Phase II trial on vaccination with autologous dendritic..:

Ridolfi, L. ; Gurrieri, L. ; Riva, M.N....
Immuno-Oncology and Technology. 16 (2022) - p. 100153 , 2022

Link: https://doi.org/10.1016/..

7

EE254 A Cost-Utility Analysis of Ferric Derisomaltose Versu..:

Cortesi, P ; Mazzaglia, G ; Rethmeier, L..
Value in Health. 25 (2022) 12 - p. S103 , 2022

Link: https://doi.org/10.1016/..

8

Challenges in economic evaluation of public health interven..:

Cortesi, P
European Journal of Public Health. 32 (2022) Supplement_3 - p. , 2022

Link: https://doi.org/10.1093/..

9

HTA237 Cost-Effectiveness Analysis of Ofatumumab for Relaps..:

Antonazzo, IC ; Nica, M ; Cortesi, P..
Value in Health. 25 (2022) 12 - p. S342-S343 , 2022

Link: https://doi.org/10.1016/..

10

Liver transplant recipients with Covid-19: results from an ..:

Mazzarelli, C. ; Viganò, R. ; Perricone, G....
Digestive and Liver Disease. 53 (2021) - p. S13 , 2021

Link: https://doi.org/10.1016/..

11

What is the rate of correct surgical indication in patients..:

Tamburrino, D. ; Cortesi, P. ; De Pretis, N....
Pancreatology. 21 (2021) - p. S93 , 2021

Link: https://doi.org/10.1016/..

12

PRO121 Assessing Physician and Patient Perspectives on Livi..:

Cortesi, P.A. ; Rocino, A. ; Coppola, A....
Value in Health. 23 (2020) - p. S711-S712 , 2020

Link: https://doi.org/10.1016/..

13

PND10 The Disability Progression of Multiple Sclerosis Prog..:

Fornari, C. ; Cortesi, P.A. ; Capra, R....
Value in Health. 23 (2020) - p. S624 , 2020

Link: https://doi.org/10.1016/..

14

PRO40 Cost-Consequence Analysis of Emicizumab Prophylaxis f..:

Cortesi, P.A. ; Castaman, G. ; Mantovani, L.G.
Value in Health. 23 (2020) - p. S696 , 2020

Link: https://doi.org/10.1016/..

15

PDG15 Evolution of Natalizumab Use in Two Italian Multiple ..:

Cozzolino, P. ; Cortesi, P.A. ; Capra, R....
Value in Health. 23 (2020) - p. S523 , 2020

Link: https://doi.org/10.1016/..